We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Half a million women in England have accessed cheaper HRT - the main treatment for negative menopause symptoms - since last April.
The equality assessment presents the impacts of the introduction of the hormone replacement therapy prescription prepayment certificate (HRT PPC).
A serious shortage protocol (SSP) has been issued across the UK for Utrogestan® 100mg capsules today (19 May 2023).
Following its Phase 1 investigation, the CMA has found that Theramex's proposed purchase of Femoston and Duphaston could reduce competition and choice for hormone replacement therapy treatments.
NHS Business Services Authority contact number for ordering prepaid prescriptions for 3 or 12 months at a cheaper rate than single prescriptions
From 1 April 2023, women in England will be able to access cheaper hormone replacement therapy (HRT) to help with menopause symptoms.
37,700 women have purchased hormone replacement therapy (HRT) prescription prepayment certificates (PPC) following the launch, saving over £1.13 million.
Around 400,000 women across England will get better access to menopause support - saving hundreds of pounds and making treatment more accessible.
The MHRA has launched a public consultation on a set of proposals to make Gina 10 microgram vaginal tablets (Estradiol) available from pharmacies.
Public consultation on a set of proposals to make Gina 10 microgram vaginal tablets (Estradiol) available from pharmacies.
Before prescribing hormone-replacement therapy, healthcare professionals should consider carefully the potential benefits and risks for every woman
Head of the HRT Taskforce Madelaine McTernan presents key recommendations for future management of hormone replacement therapy (HRT) supply.
Problem periods, women’s health research and support for domestic and sexual abuse victims are among the government’s priorities.
The government has announced that Madelaine McTernan CB has been appointed as head of the newly formed HRT taskforce to address issues in the supply chain.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.